Skip to main content
Sam-A Pharm. Co. Ltd logo

Sam-A Pharm. Co. Ltd — Investor Relations & Filings

Ticker · 009300 ISIN · KR7009300005 KO Manufacturing
Open in API
Filings indexed 105 across all filing types
Latest filing 2025-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 009300

About Sam-A Pharm. Co. Ltd

https://www.samapharm.co.kr/eng/main201…

Sam-A Pharm. Co. Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a range of pharmaceutical products. The company specializes in several therapeutic areas, with a primary focus on treatments for respiratory and dermatological conditions. Its portfolio also includes antipyretic, analgesic, and anti-inflammatory medications. Founded in 1945, Sam-A Pharm. operates manufacturing facilities that adhere to high-quality production standards, equivalent to EU-GMP, reflecting its long-standing commitment to improving health and quality of life.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Sam-A Pharmaceutical. It details the approval of financial statements, dividend resolutions, election of directors, and other agenda items voted upon during the meeting. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2025-03-28 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Sam-A Pharm Co., Ltd. for the 52nd fiscal year (2024). It contains detailed financial information, business operations, management structure, and shareholding data. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report. It is a comprehensive annual filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2024
2025-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Sam-A Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit), and auditor information. According to the 'Menu vs Meal' rule, this is an announcement of the audit report's submission rather than the full audit report itself, making it a Report Publication Announcement. FY 2024
2025-03-20 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the agenda, director candidates, financial statements, and dividend proposals. While it contains financial data, it is specifically a proxy solicitation document rather than an Annual Report (10-K) or an Earnings Release (ER). Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Sam-A Pharmaceutical. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as financial statement approval, board appointments, and remuneration limits. While it contains financial data, this is provided as part of the proxy materials to inform shareholders ahead of the meeting, which is standard for a Proxy Solicitation & Information Statement (PSI) in the Korean regulatory context.
2025-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Sam-A Pharmaceutical. It outlines the date, location, and agenda items (financial statements, dividend approval, director appointments) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.